Tenax Therapeutics Inc.

Tenax Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Tenax Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -16.6 M, a 46.17% increase year-over-year.
• Tenax Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -35.2 M, a 311.49% increase year-over-year.
• Tenax Therapeutics Inc. annual operating income for 2025 was -56.4 M, a 189.24% increase from 2024.
• Tenax Therapeutics Inc. annual operating income for 2024 was -19.5 M, a 62.97% decrease from 2016.
• Tenax Therapeutics Inc. annual operating income for 2016 was -52.7 M, a 255.35% increase from 2015.
• Tenax Therapeutics Inc. annual operating income for 2015 was -14.8 M.